Genetics of type 2 diabetes.

Type 2 diabetes (T2D) is the result of interaction between environmental factors and a strong hereditary component. We review the heritability of T2D as well as the history of genetic and genomic research in this area. Very few T2D risk genes were identified using candidate gene and linkage-based studies, but the advent of genome-wide association studies has led to the identification of multiple genes, including several that were not previously known to play any role in T2D. Highly replicated genes, for example TCF7L2, KCNQ1 and KCNJ11, are discussed in greater detail. Taken together, the genetic loci discovered to date explain only a small proportion of the observed heritability. We discuss possible explanations for this "missing heritability", including the role of rare variants, gene-environment interactions and epigenetics. The clinical utility of current findings and avenues of future research are also discussed.

[1]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[2]  K. Clément,et al.  The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes , 2000, International Journal of Obesity.

[3]  T. Hansen,et al.  Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1 , 1995, The Lancet.

[4]  Claude Bouchard,et al.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.

[5]  F. Bastardot,et al.  Current genetic data do not improve the prediction of type 2 diabetes mellitus: the CoLaus study. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  B. Balkau,et al.  Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians , 2008, Diabetes.

[7]  N. Schork,et al.  Genotype Prediction of Adult Type 2 Diabetes From Adolescence in a Multiracial Population , 2012, Pediatrics.

[8]  B. Dallapiccola,et al.  Genetic prediction of common diseases. Still no help for the clinical diabetologist! , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[10]  K. T. Chen,et al.  Epidemiology of Diabetes Mellitus , 1992 .

[11]  M. Laakso,et al.  Adipose Tissue TCF7L2 Splicing Is Regulated by Weight Loss and Associates With Glucose and Fatty Acid Metabolism , 2012, Diabetes.

[12]  L. Chuang,et al.  Association Study of the Genetic Polymorphisms of the Transcription Factor 7-Like 2 (TCF7L2) Gene and Type 2 Diabetes in the Chinese Population , 2007, Diabetes.

[13]  W. Almawi,et al.  Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Lebanese subjects. , 2012, Diabetes research and clinical practice.

[14]  S. Humphries,et al.  Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.

[15]  A. Das,et al.  History of diabetes: from ants to analogs. , 2011, The Journal of the Association of Physicians of India.

[16]  M. Permutt,et al.  Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR ): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians , 1998, Diabetologia.

[17]  C. Bouchard,et al.  Evidence for Interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser Polymorphisms in Determining Type 2 Diabetes Intermediate Phenotypes in Overweight Subjects , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[18]  T. Hansen,et al.  Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test , 2010, Diabetologia.

[19]  Zhaoqian Liu,et al.  IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population , 2010, Acta Pharmacologica Sinica.